Category: Longevity & Anti-Aging
-

NAD IV therapy costs $200 to $1,000 a session. A 2026 review of 113 studies found zero trials of the drip itself. Here is what the evidence really shows.
-

Plasma exchange longevity claims rest on one 42-person trial where a biological age score fell 2.6 years. No strength, memory or illness was measured.
-

An audit ran the same 16 epigenetic clocks across 51 human trials. Only 19 interventions did anything to slow biological aging, and few were supplements.
-

Menopause hormone therapy relieves hot flushes and protects bone, but it is not a prevention drug. What 20 years of Women’s Health Initiative data show.
-

The biggest trial of testosterone therapy risks found no extra heart attacks, but more irregular heartbeats, lung clots and broken bones. The full picture.
-

A biological age test can be off by 9 years on a single blood sample. Here is what epigenetic clocks really measure, and which numbers to track instead.
-

Do brain training games work? 11,430 adults trained for six weeks and gained nothing on untrained tests. What the evidence shows, and what helps instead.
-

The hearing loss dementia link got its first proper trial: 977 adults, three years, hearing aids. Here is what it found, and what the headline number missed.
-

Are seed oils bad for you? Across 221,054 adults followed for 33 years, more plant oil tracked with lower death rates, and more butter with higher ones.
-

The fisetin senolytic case rests on mice. The biggest human trial found no benefit at 12 months, and the two Mayo trials still have not posted results.